References
- Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost. 2003;9:177–90.
- Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Hematol. 2001;74:397–404.
- Schmitz G, Rothe G, Ruf A, Barlage S, Tschope D, Clemetson KJ, et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost. 1998;79:886–96.
- Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JR. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet derived micro-particles. Blood. 1991;77:2641–8.
- Siljander P, Carpen 0, Lassila R. Platelet derived micro-particles associate with fibrin during thrombosis. Blood. 1996;87:4651–63.
- Tan KT, Lip GYH. Platelets, atherosclerosis, and the endothelium: new therapeutic targets? Exp Opin Investig Drugs. 2003;12:1765–76.
- Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001;103:491–5.
- Blann AD, Faragher EB, McCollum CN. Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis. Blood Coagul Fibrinolysis. 1997;8:383–90.
- Zeiger F, Stephan S, Hoheisel G, Pfeiffer D, Ruehlmann C, Koksch M. P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis. 2000;11:723–8.
- Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196: 887–96.
- Huo Y, Schober A, Forlow SB, Snutg DF, Hyman MC, Jung S, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61–7.
- Berckmans RJ, Neiuwland R, Boing AN, Romijin FP, Hack CE, Sturk A. Cell derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost. 2001;85:639–46.
- Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijin FP, Hack CE, et al. Microparticles from patientswith multiple organ dysfunction syndrome and sepsis supports coagulation through multiple mechanisms. Thromb Haemost. 2001;85:810–20.
- Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, Kambayashi J. High shear stress induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis. 2001;158:277–87.
- Barry OP, Pratico D, Savani RC, Fitzgerald GA. Modulation of monocyte-endothelial cell interactions by platelet micro-particles. J Clin Invest. 1998;102:136–44.
- Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu P, Tedgui A, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dys-function. Circulation. 2001;104:2649–52.
- Pfister SL. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension. 2004;43:428–33.
- Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A. 1996;93:11877–82.
- Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, et al. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation. 2003;108:524–9.
- Blann AD, Seigneur M, Boisseau M, Taberner DA, McCollum CN. Increased plasma P-selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factors. Blood Coag Fibrinolysis. 1996;7:789–93.
- Kagawa H, Nomura S, Nagahama M, Ozaki Y, Fukuhara S. Effect of ticlopidine on platelet derived microparticles in patients with connective tissue disease. Haemostasis. 1999;29:255–61.
- Kagawa H, Nomura S, Nagahama M, Ozaki Y, Fukuhara S. Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia. Chin Appl Thromb Hemost. 2001;7:153–7.